No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
45 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Georgetown University · Other
Who this trial is looking for
This trial is looking for participants aged 45 and older to help assess new tests for Alzheimer's disease and related conditions. Taking part involves providing blood or cerebrospinal fluid samples and undergoing cognitive assessments.
Are You a Good Fit for This Trial?
You may be able to join if
I am 45 years old or older.
I am 45 to 50 years old and have a first degree relative with a neurodegenerative disease.
You may not be able to join if
I am under 45 years old.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal changes in biological, lifestyle, and cognitive assessment collection.
The primary goal of this stud…
The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal changes in biological, lifestyle, and cognitive assessment collection.
The primary goal of this study is to examine the feasibility of biochemical assays, genetic testing, and cognitive and lifestyle assessments in the ante-mortem diagnosis of Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. This research involves genetic and cognitive status testing but the findings will not be shared with research subjects. This will be accomplished ex vivo using blood, and/or cerebrospinal fluid (CSF) specimens from patients with a diagnosis of probable Alzheimer's disease, mild cognitive impairment, or other neurodegenerative diseases and from normal controls.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age 45 and older.
* Subjects within the age range of 45-50 years old must have a first degree relative with a neurodegenerative disease.
Exclusion Criteria:
* Individuals under 45 years of age
Inclusion Criteria:
* Age 45 and older.
* Subjects within the age range of 45-50 years old must have a first degree relative with a neurodegenerative disease.
Exclusion Criteria:
* Individuals under 45 years of age
Contacts
No contact information available.
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.